Millennium Management’s Thermo Fisher Scientific TMO Stock Holding History

Millennium Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.2M	Sell	49,300 -31,300	-39%	-$17M	0.01%	1395
2025 Q4	$46.7M	Buy	80,600 +41,600	+107%	+$23.5M	0.02%	873
2025 Q3	$18.9M	Sell	39,000 -13,900	-26%	-$6.47M	0.01%	1718
2025 Q2	$21.4M	Sell	52,900 -19,400	-27%	-$8.11M	0.01%	1510
2025 Q1	$36M	Buy	72,300 +700	+1%	+$379K	0.02%	1003
2024 Q4	$37.2M	Buy	71,600 +22,800	+47%	+$12.5M	0.02%	999
2024 Q3	$30.2M	Sell	48,800 -62,800	-56%	-$37.2M	0.01%	1189
2024 Q2	$61.7M	Buy	111,600 +7,800	+8%	+$4.47M	0.03%	674
2024 Q1	$60.3M	Sell	103,800 -61,500	-37%	-$34.5M	0.03%	712
2023 Q4	$87.7M	Buy	165,300 +57,300	+53%	+$27.7M	0.04%	483
2023 Q3	$54.7M	Buy	108,000 +19,700	+22%	+$10.5M	0.03%	646
2023 Q2	$46.1M	Buy	88,300 +59,900	+211%	+$32.3M	0.02%	790
2023 Q1	$16.4M	Sell	28,400 -121,900	-81%	-$68.7M	0.01%	1514
2022 Q4	$82.8M	Buy	150,300 +122,800	+447%	+$65.1M	0.05%	473
2022 Q3	$13.9M	Buy	27,500 +13,000	+90%	+$7.28M	0.01%	1742
2022 Q2	$7.88M	Buy	14,500 +8,200	+130%	+$4.51M	﹤0.01%	2313
2022 Q1	$3.72M	Sell	6,300 -30,900	-83%	-$17.8M	﹤0.01%	3256
2021 Q4	$24.8M	Sell	37,200 -44,500	-54%	-$27.8M	0.01%	1250
2021 Q3	$46.7M	Buy	81,700 +60,200	+280%	+$33M	0.03%	673
2021 Q2	$10.8M	Buy	21,500 +4,500	+26%	+$2.12M	0.01%	1804
2021 Q1	$7.76M	Sell	17,000 -12,300	-42%	-$5.87M	0.01%	2072
2020 Q4	$13.6M	Sell	29,300 -16,400	-36%	-$7.69M	0.01%	1393
2020 Q3	$20.2K	Sell	45,700 -2,700	-6%	-$1.12M	0.02%	797
2020 Q2	$17.5M	Buy	48,400 +38,400	+384%	+$12.9M	0.02%	815
2020 Q1	$2.84M	Buy	+10,000	New	+$3.15M	0.01%	1769
2019 Q4	–	Sell	-2,600	Closed	-$757K	–	4634
2019 Q3	$757K	Buy	+2,600	New	+$745K	﹤0.01%	3022
2019 Q1	–	Sell	-5,000	Closed	-$1.12M	–	4329
2018 Q4	$1.12M	Buy	+5,000	New	+$1.17M	﹤0.01%	2524
2014 Q2	–	Sell	-30,000	Closed	-$3.61M	–	3877
2014 Q1	$3.61M	Buy	+30,000	New	+$3.57M	0.01%	1404

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management's TMO Position: Q1 2026 in Review

Millennium Management increased its Thermo Fisher Scientific (TMO) stake by 35% in Q1 2026, buying an estimated $10M and bringing the position to 70,696 shares worth $34.7M. The position accounts for 0.01% of the portfolio, ranked #1110.

Millennium Management first reported a position in TMO in Q2 2013 and has held it in 50 quarters since. The position peaked at $313M in Q2 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Millennium Management held 70,696 shares of Thermo Fisher Scientific worth $34.7M as of Q1 2026.
Millennium Management bought 18,432 Thermo Fisher Scientific shares in Q1 2026, an estimated $10M.
Thermo Fisher Scientific made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1110 holding.
Millennium Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 50 quarters since.
Millennium Management's Thermo Fisher Scientific position peaked at $313M in Q2 2024.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.